Callori Fred 4/A
4/A · Astria Therapeutics, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4/AAmended
Callori Fred
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-09+8,333→ 8,333 totalExercise: $3.00Exp: 2032-06-08→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]This amendment is being made to show the correct price of $3.00. An incorrect price of $2.99 was previously reported.
- [F2]This option was granted on June 9, 2022 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.